Oncology - European Medical Journal

Continue

Oncology

Filter
EMJ Oncology 8 [Supplement 4] 2020 Feature Image
6 Mins
16 Dec 2020

3rd Breast Cancer Virtual Masterclass Symposium: MONARCH 2, a Phase III Study of Abemaciclib or Placebo in Combination with Fulvestrant

More than 70% of patients diagnosed with metastatic breast cancer present with oestrogen-HR+ disease and are therefore candidates for endocrine…
EMJ Oncology 8.1 2020 Feature Image
8 Mins
5 Nov 2020

Next-Generation Sequencing Standard of Care for Molecular Profiling

Given that COVID-19 has posed unique challenges in cancer care, a number of speakers addressed, with evidence, the impact of COVID-19…
11 Mins
5 Nov 2020

Oncogenic Drivers in Advanced NSCLC: Navigating an Evolving Landscape to Optimise Patient Outcomes

The oncology community has been experiencing an unprecedented moment in lung cancer diagnosis and treatment; however, despite significant…
EMJ Oncology 8 [Supplement 2] 2020
8 Mins
26 Aug 2020

Review of the Latest Developments in Treatment of Hormone Receptor-Positive Advanced Breast Cancer

MONARCH 2 was a global, randomised, double-blind, Phase III study of abemaciclib or placebo in combination with fulvestrant in premenopausal…
8 Mins
20 Dec 2019

BCG-Unresponsive Bladder Cancer: New Frontiers in the Treatment Landscape

This meeting took place on 28th September 2019, as part of the Ferring-organised Meet-The-Expert symposium at the European Society of Medical Oncology. Main topic is discussion of new treatment modalities in the management of high-risk, non-muscle invasive bladder cancer.
9 Mins
12 Nov 2019

Inflection Point: Novel Treatment Options are Forcing Next-Generation Sequencing into Standard of Care for Molecular Profiling in Oncology

With a sustained number of new drugs or combination drugs entering standard of care this year, molecular testing should be…
9 Mins
6 Dec 2018

The Right Therapy Starts with the Right Test: Novel Therapeutic Approaches in Oncology Foster the Need for an Appropriate Molecular Profiling Strategy

Adding a molecular perspective to the traditional multidisciplinary management of cancer patients is substantially hampering the adoption of precision…
8 Mins
6 Dec 2018

Prediction with Precision: Does TAILORx Make Chemotherapy a Personalised Treatment?

Adjuvant chemotherapy (CT) is commonly recommended to breast cancer patients following surgery. However, not all patients benefit from it, and the…
We’ve noticed you’re accessing
from North/South America.